Machine Learning Enabled Structure-Based Drug Repurposing Approach to Identify Potential CYP1B1 Inhibitors

[Image: see text] Drug-metabolizing enzyme (DME)-mediated pharmacokinetic resistance of some clinically approved anticancer agents is one of the main reasons for cancer treatment failure. In particular, some commonly used anticancer medicines, including docetaxel, tamoxifen, imatinib, cisplatin, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Raju, Baddipadige, Narendra, Gera, Verma, Himanshu, Kumar, Manoj, Sapra, Bharti, Kaur, Gurleen, jain, Subheet Kumar, Silakari, Om
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476183/
https://www.ncbi.nlm.nih.gov/pubmed/36120033
http://dx.doi.org/10.1021/acsomega.2c02983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476183/
https://www.ncbi.nlm.nih.gov/pubmed/36120033
http://dx.doi.org/10.1021/acsomega.2c02983

Ejemplares similares